Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.
Amit M. Oza
Disclosure not yet available
David Cibula
Disclosure not yet available
Ana Oaknin
Disclosure not yet available
Christopher John Poole
Disclosure not yet available
Ron H.J. Mathijssen
Disclosure not yet available
Gabe S. Sonke
Disclosure not yet available
Nicoletta Colombo
Disclosure not yet available
Jirí Špacek
Disclosure not yet available
Peter Vuylsteke
Disclosure not yet available
Hal W. Hirte
Disclosure not yet available
Sven Mahner
Disclosure not yet available
Marie Plante
Disclosure not yet available
Barbara Schmalfeldt
Disclosure not yet available
Helen Mackay
Disclosure not yet available
Jacqui Rowbottom
Disclosure not yet available
Ilian Tchakov
Disclosure not yet available
Michael Friedlander
Disclosure not yet available